Hims & Hers Health (HIMS)

NYSE Market Closed

Hims & Hers Health, Inc. is a consumer-focused telehealth company that connects patients with licensed medical providers through digital platforms branded as Hims and Hers. The company targets common, often stigmatized health and wellness categories by combining online consultations, personalized treatment plans, and direct-to-consumer fulfillment.

Its services cover areas such as sexual health, hair loss, dermatology, mental health, primary care, and weight management. Products may include generic and branded prescription medicines, compounded prescriptions where permitted, over-the-counter treatments, supplements, cosmetics, and related wellness items. The platform is designed to make care feel more accessible and discreet, with asynchronous or virtual provider interactions, electronic medical records, and pharmacy fulfillment integrated into the customer experience.

Hims & Hers operates primarily on a cash-pay model rather than relying on insurance reimbursement. Customers typically pay directly for visits, subscriptions, and products, which gives the company more control over pricing and user experience but also makes affordability and retention important drivers of growth. Its subscription model is a key part of the business, supporting recurring revenue and ongoing engagement for treatments that require continuity.

The company is available across the United States and has expanded into select international markets, including the UK. Its competitive position rests on brand recognition, digital marketing, clinical network management, convenience, and the ability to personalize offerings at scale. As with other healthcare platforms, it operates within a highly regulated environment covering prescribing practices, pharmacy operations, advertising, privacy, and state-by-state medical rules.

27.51 USD
26.93 USD
+0.00 (0.00%)
Pre-market

Last updated

Market Cap
6.37B
P/E
P/FCF
95.21
P/S
2.69
Enterprise Value
7.12B
Sector
Health Care
Industry
Offices and Clinics of Doctors of Medicine
Address
2269 CHESTNUT ST, SAN FRANCISCO, CA, 94123
Investing.com

Hims & Hers Debt-Funded Expansion Tests Its Global Telehealth Ambitions

28 May 2026, 16:44 PM
Investing.com

S&P 500 Valuation Looks Stretched as Inflation Reprices Rate-Cut Odds

13 May 2026, 17:22 PM
Investing.com

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recov

12 May 2026, 18:49 PM
Invezz

Hims & Hers tumbles 15% after earnings miss as GLP-1 transition weighs on results

12 May 2026, 12:48 PM
Investing.com

Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus

08 May 2026, 17:20 PM
Investing.com

3 Sectors to Buy While They’re Down and 1 to Walk Away From

07 Apr 2026, 16:31 PM
GlobeNewswire Inc.

Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach

04 Apr 2026, 00:23 AM
Investing.com

Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside

24 Feb 2026, 15:35 PM
GlobeNewswire Inc.

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

06 Feb 2026, 02:51 AM
GlobeNewswire Inc.

PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026

06 Feb 2026, 01:53 AM
GlobeNewswire Inc.

Kelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch

26 Jan 2026, 19:00 PM
Investing.com

High Short-Interest Stocks to Buy Before Q1 2026

10 Dec 2025, 16:12 PM
Investing.com

3 Healthcare Stocks Using AI to Drive Growth

30 Sept 2025, 22:04 PM
Investing.com

Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy

23 Sept 2025, 15:36 PM
GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

25 Aug 2025, 15:57 PM
GlobeNewswire Inc.

Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman

24 Aug 2025, 15:26 PM
GlobeNewswire Inc.

HIMS DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS

24 Aug 2025, 14:46 PM
GlobeNewswire Inc.

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS

23 Aug 2025, 14:45 PM
GlobeNewswire Inc.

DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

22 Aug 2025, 17:00 PM
GlobeNewswire Inc.

HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS

22 Aug 2025, 03:22 AM
Market Cap
6.37B
Enterprise Value
7.12B
P/E
P/B
14.27
P/S
2.69
EV / EBITDA
189.48
EV / Sales
3
EPS
-0.06
Dividend Yield
0%
P/FCF
95.21
P/CF
22.72
Free Cash Flow
66.88M
ROE
-2.97%
ROA
-0.58%
Debt / Equity
2.18
Current Ratio
1.69
Quick Ratio
1.56
Cash
0.36
Avg Volume
23.88M
Fundamentals Snapshot Price
27.51

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 608.1M 617.82M 598.98M 544.83M 586.01M
Gross profit 396.79M 444.44M 442.06M 416.2M 430.69M
Operating income -78.32M 9.19M 11.81M 26.72M 57.9M
EBITDA -56.37M 27.28M 29.48M 37.19M 66.17M
Net income -92.12M 20.6M 15.77M 42.51M 49.49M
Basic EPS -0.4 0.09 0.07 0.19 0.22
Diluted EPS -0.4 0.08 0.06 0.17 0.2

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 2.27B 2.15B 2.23B 1.88B 891.71M
Total liabilities 1.82B 1.61B 1.65B 1.31B 342.45M
Total equity 446.17M 540.93M 580.98M 562.7M 549.26M
Cash & equivalents 222.27M 228.62M 345.78M 1.12B 273.74M
Current assets 1.05B 767.64M 845.26M 1.36B 446.96M
Current liabilities 618.78M 404.43M 450.79M 272.23M 280.36M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 89.36M 61.31M 148.72M -19.12M 109.09M
Investing cash flow -15.45M -83.68M -887.4M -21.09M -32.8M
Financing cash flow -77.88M -97.52M -39.01M 889.17M -23.02M
Change in cash -6.35M -117.16M -779.17M 849.99M 53.52M
Kind Filing Date Link
edgar index 8-K — Hims & Hers Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
form 4 Form 4 — WELLS DAVID B View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 8-K — Hims & Hers Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — WELLS DAVID B View Filing
form 4 Form 4 — Payne Christopher D View Filing
form 4 Form 4 — Carroll Patrick Harrison View Filing
edgar index 8-K — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
edgar index SCHEDULE 13G — Hims & Hers Health, Inc. View Filing
edgar index SCHEDULE 13G/A — Hims & Hers Health, Inc. View Filing
edgar index 8-K — Hims & Hers Health, Inc. View Filing
edgar index 10-Q — Hims & Hers Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index ARS — Hims & Hers Health, Inc. View Filing
edgar index DEF 14A — Hims & Hers Health, Inc. View Filing
edgar index DEFA14A — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 144 — Hims & Hers Health, Inc. View Filing
form 4 Form 4 — Boughton Soleil View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
form 4 Form 4 — Dudum Andrew View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 144 — Hims & Hers Health, Inc. View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
edgar index SCHEDULE 13G/A — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
form 4 Form 4 — Okupe Oluyemi View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 4 — Hims & Hers Health, Inc. View Filing
edgar index 144 — Hims & Hers Health, Inc. View Filing